We are live on ! Find out more

504 hedge funds and large institutions have $9.8B invested in Sanofi in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 126 increasing their positions, 197 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $22.5M | Put options by funds: $11.3M

4% more funds holding

Funds holding: 484 → 504 (+20)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

0.14% less ownership

Funds ownership: 9.12% → 8.98% (-0.14%)

36% less repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 197

40% less capital inflows, than outflows

Capital inflows: $288M | Capital outflows: $478M

55% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 53

Holders
504
Holders Change
+20
Holders Change %
+4.13%
% of All Funds
11.41%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
24
Increased
126
Reduced
197
Closed
53
Calls
$22.5​M
Puts
$11.3​M
Net Calls
+$11.1​M
Net Calls Change
+$15​M

SNY Hedge Fund Activity: Q4 2017 in Review

504 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2017, worth a combined $9.8B — down 14% from $11.4B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of SNY and 24 opened new positions — a net loss of 29 holders — while 197 trimmed existing stakes and 126 added.

The largest buyer was Fidelity Investments, adding an estimated $90.6M. The largest seller was Bank of America, cutting an estimated $82.1M.

  • 504 institutional investors held Sanofi (SNY) as of Q4 2017, up from 484 in Q3 2017.
  • Funds reported $9.8B of Sanofi stock for Q4 2017, down 14% quarter-over-quarter.
  • 24 funds opened new Sanofi positions in Q4 2017 and 53 closed out, a net change of -29 holders.
  • The largest Sanofi buyer in Q4 2017 was Fidelity Investments, an estimated $90.6M added.
  • The largest Sanofi seller in Q4 2017 was Bank of America, an estimated $82.1M sold.

Based on aggregated 13F filings for Q4 2017.